CLINICAL_TRIALS
trial_result
· 2008-12-18
Clinical Trial Update: A Phase II, Open-Label Trial Evaluating GV1001 in Advanced Hepatocellular Carcinoma. [Phase 2]
Summary
Phase II open-label trial evaluating GV1001 in advanced hepatocellular carcinoma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pharmexa A/S | Conditions: Carcinoma, Hepatocellular | Phase 2 | Status: COMPLETED